Evidence-Based Intelligence from Trusted Sources
Wilbur Salt OS integrates data from clinical trials, peer-reviewed literature, regulatory agencies, real-world evidence, and market intelligence sources to deliver comprehensive pharmaceutical insights.
Data Source Categories
Our platform aggregates and analyzes data from multiple categories to provide a complete picture of the pharmaceutical landscape.
Clinical Trials
Real-time access to clinical trial registries and results databases for comprehensive trial landscape analysis.
ClinicalTrials.gov
apiU.S. National Library of Medicine registry of clinical studies conducted around the world.
EU Clinical Trials Register
apiEuropean Medicines Agency database of clinical trials conducted in the European Union.
WHO ICTRP
apiWorld Health Organization International Clinical Trials Registry Platform.
Peer-Reviewed Literature
Access to medical and scientific publications for evidence-based insights and literature reviews.
PubMed / MEDLINE
apiNCBI database of biomedical literature from MEDLINE, life science journals, and online books.
PubMed Central
apiFree full-text archive of biomedical and life sciences journal literature.
Cochrane Library
databaseCollection of databases containing high-quality, independent evidence for healthcare decision-making.
Regulatory Intelligence
Official regulatory agency data including drug approvals, safety alerts, and labeling information.
FDA DailyMed
apiOfficial FDA-approved drug labeling (package inserts) and medication guides.
FDA Drugs@FDA
apiFDA-approved drug products with approval history, labels, and reviews.
EMA Medicines Database
apiEuropean Medicines Agency database of human and veterinary medicines.
FDA FAERS
databaseFDA Adverse Event Reporting System for post-market safety surveillance.
Real-World Evidence
Real-world data sources for outcomes research, market access, and health economics analysis.
IHME Global Burden of Disease
databaseInstitute for Health Metrics and Evaluation comprehensive disease burden data.
CDC WONDER
apiWide-ranging Online Data for Epidemiologic Research from the CDC.
OpenFDA
apiFDA open data APIs for drugs, devices, and food safety.
Clinical Guidelines
Evidence-based clinical practice guidelines from medical societies and health technology assessment bodies.
NICE Guidelines
databaseNational Institute for Health and Care Excellence clinical guidelines and technology appraisals.
ICER Reports
databaseInstitute for Clinical and Economic Review value assessments and evidence reports.
G-BA Decisions
databaseGerman Federal Joint Committee benefit assessments for pharmaceuticals.
NCCN Guidelines
databaseNational Comprehensive Cancer Network clinical practice guidelines in oncology.
News & RSS Feeds
Real-time news and updates from regulatory agencies, research institutions, and industry sources.
FDA Press Releases
feedOfficial FDA announcements including drug approvals, safety communications, and policy updates.
EMA News
feedEuropean Medicines Agency news and press releases.
NIH News
feedNational Institutes of Health research news and discoveries.
CDC Newsroom
feedCenters for Disease Control and Prevention public health updates.
PubMed Trending
feedTrending articles and most-cited publications in biomedical research.
Medical Congresses
Coverage of major medical society meetings and scientific conferences worldwide.
Global Medical Congresses
manualAll sponsored congresses, all global, US and European based top congresses covered. Additional congresses added by customer request.
Market Intelligence
Competitive intelligence data including patent information, pricing, and market dynamics.
USPTO Patent Database
apiU.S. Patent and Trademark Office patent search and full-text database.
Orange Book
databaseFDA publication of approved drug products with therapeutic equivalence evaluations.
Purple Book
databaseFDA database of licensed biological products including biosimilar information.
Unified Analysis Across Sources
Our platform doesn't just aggregate data—it synthesizes insights across all sources to identify patterns, validate hypotheses, and surface opportunities that would be invisible when analyzing sources in isolation.